Spots Global Cancer Trial Database for advanced malignant tumors
Every month we try and update this database with for advanced malignant tumors cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Clinical Trial of IBC0966 in Patients With Advanced Malignant Tumors | NCT04980690 | Advanced Malign... | IBC0966 | 18 Years - 75 Years | SUNHO（China）BioPharmaceutical CO., Ltd. | |
| A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3804 in Subjects With Advanced Malignant Tumors | NCT04128085 | Advanced Malign... | TQB3804 | 18 Years - 70 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| A Trial of SHR-2002 Injection or Combined With Other Anti-cancer Medication in Advanced Malignant Tumors of Patients | NCT05198817 | Advanced Malign... | SHR-2002 inject... | 18 Years - 70 Years | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | |
| A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors | NCT05235542 | Advanced Malign... | AK104 AK117 Capecitabine ta... Oxaliplatin Cisplatin Paclitaxel Irinotecan Docetaxel 5-FU | 18 Years - 75 Years | Akeso | |
| A Clinical Trial to Evaluate Effect of IBB0979 in Patients With Advanced Malignant Tumors | NCT05991583 | Advanced Malign... | IBB0979 | 18 Years - 80 Years | SUNHO（China）BioPharmaceutical CO., Ltd. | |
| Study of Urelumab in Subjects With Advanced and/or Metastatic Malignant Tumors | NCT02534506 | Malignant Tumor... | Urelumab Nivolumab | 20 Years - | Bristol-Myers Squibb | |
| A Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB3617 Capsule in Patients With Advanced Malignant Tumors | NCT05110807 | Advanced Malign... | TQB3617 | 18 Years - | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| Clinical Trial of IBC0966 in Patients With Advanced Malignant Tumors | NCT04980690 | Advanced Malign... | IBC0966 | 18 Years - 75 Years | SUNHO（China）BioPharmaceutical CO., Ltd. | |
| A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors | NCT06223841 | Advanced Malign... | IAP0971 | 18 Years - 75 Years | SUNHO（China）BioPharmaceutical CO., Ltd. | |
| A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors | NCT05396391 | Advanced Malign... | IAP0971 | 18 Years - 80 Years | SUNHO（China）BioPharmaceutical CO., Ltd. | |
| Study on the Correlation Between Immunoglobulin and Liposomal Doxorubicin in Vivo | NCT05354076 | Advanced Malign... | doxorubicin hyd... | 18 Years - 70 Years | Fudan University | |
| Study of the Efficacy and Safety of IBI319 in Patients With Advanced Malignant Tumors | NCT04708210 | Advanced Malign... | IBI319 | 18 Years - 75 Years | Innovent Biologics (Suzhou) Co. Ltd. | |
| A Study of AK130 in Patients With Advanced Malignant Tumors | NCT05653284 | Advanced Malign... | AK130 | 18 Years - 75 Years | Akeso | |
| A Clinical Trial to Evaluate Effect of IBB0979 in Patients With Advanced Malignant Tumors | NCT05991583 | Advanced Malign... | IBB0979 | 18 Years - 80 Years | SUNHO（China）BioPharmaceutical CO., Ltd. | |
| A Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant Tumors | NCT05229497 | Advanced Malign... | AK112 AK117 Carboplatin Cisplatin 5-Fluorouracil | 18 Years - 75 Years | Akeso | |
| Study of Urelumab in Subjects With Advanced and/or Metastatic Malignant Tumors | NCT02534506 | Malignant Tumor... | Urelumab Nivolumab | 20 Years - | Bristol-Myers Squibb | |
| A Phase I/II Clinical Trial of LBL-033 in the Treatment of Advanced Malignant Tumors | NCT05779163 | Advanced Malign... | LBL-033 for Inj... | 18 Years - | Nanjing Leads Biolabs Co.,Ltd | |
| Dose Escalation and Expansion Study of SYH2043 in Patients With Advanced Malignant Tumors | NCT05728541 | Advanced Malign... | SYH2043 | 18 Years - 75 Years | CSPC Ouyi Pharmaceutical Co., Ltd. | |
| Evaluation of LBL-019 Monotherapy or Combined With Anti-PD-1 Antibody in the Treatment of Advanced Malignant Tumors | NCT05223231 | Advanced Malign... | LBL-019 Injecti... anti-PD-1 antib... | 18 Years - 75 Years | Nanjing Leads Biolabs Co.,Ltd | |
| A Study of AK112 in Advanced Malignant Tumors | NCT05214482 | Advanced Malign... | AK112 AK117 Chemotherapy | 18 Years - 75 Years | Akeso | |
| A Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant Tumors | NCT05229497 | Advanced Malign... | AK112 AK117 Carboplatin Cisplatin 5-Fluorouracil | 18 Years - 75 Years | Akeso | |
| A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3804 in Subjects With Advanced Malignant Tumors | NCT04128085 | Advanced Malign... | TQB3804 | 18 Years - 70 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| Phase I Study of SHR-2002 + SHR-1316 in Patients With Advanced Malignant Tumors | NCT05082545 | Advanced Malign... | SHR-2002 and SH... | 18 Years - | Atridia Pty Ltd. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
